Show
Sort by
-
Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
-
Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents
-
Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis
-
Synthesis, radiosynthesis and in vivo evaluation in mice of [I-123]-(4-fluorophenyl) {1-[2-(4-iodophenyl)ethyl]piperidin-4-yl}methanone for visualization of the 5-HT2A receptor with SPECT
-
In vitro and in vivo evaluation of [I-123]-VEGF(165) as a potential tumor marker
-
Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents
-
In vivo evaluation of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno [3,4-c]pyridin-5-one: a presumed dopamine D-4 receptor ligand for SPECT studies
-
Synthesis, quality control and in vivo evaluation of [I-123] rhTIMP-2, a potential tumour-imaging agent
-
Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice
-
In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies
-
Synthesis of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyri din-5-one, a potential dopamine D4 ligand for SPECT studies
-
Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents
-
Precursor synthesis, radiosynthesis and in vivo evaluation in mice of [I-123]-(4-fluorophenyl) {1-[2-(2-iodophenyl)ethyl]piperidin-4-yl}-methanone and -methanol, as potential SPECT tracers for the 5-HT2A-receptor
-
Radiosynthesis and in vivo evaluation of a carboxylic MMP inhibitor as potential SPECT tumour imaging agent
-
Synthesis, radiosynthesis and preliminary in vivo evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging